EGFR and hepatocellular carcinoma: Lipid-based mechanisms can regulate cell death mechanisms in cancer [47], and some lipid classes, e.g., GM3, which exhibits increased levels in late HCC stage x+m+ samples (Fig. 3A), can inhibit EGFR function [35] suggesting that the levels of some lipids in the transgenic models could be associated with late HCC stage cell death.